A
Arctic Therapeutics
Biotech & Life Sciences · Reykjavík, Iceland · Founded 2015
Transforming drug discovery and development by harnessing the power of applied of genomics MoreLess
AT is a drug discovery and development company, focused on identifying the genetic underpinnings of rare and common diseases. The company uses bioinformatic approaches and AI to eliminate significant risks associated with traditional drug development as well as sharply reducing the enormous cost associated with traditional drug discovery and development. The company is advancing to frontrunners further into the clinic - AT-001 for the treatment of rare and common forms of dementia, and AT-004 for inflammatory skin diseases, ranging from acne vulgaris and atopic dermatitis. Keywords: Healthcare Devices, Services, Supplies, Drug Development, Drug Discovery, Drug Discovery Firm, Drug Discovery Tech, Genealogical Database, Genetic Testing, Novel Therapies, Novel Therapies Development.
Company overview
Arctic Therapeutics company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2015
- Headquarters
- Reykjavík, Iceland
- Employees
- 20
- Open positions
- None listed
- Dealroom signal
- 76.9
Valuation & funding
Arctic Therapeutics funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jan 2025 | $29M | $117M | Kerecis · EIC Fund · Kaldbakur · Sanos Group | ↗ |
| GRANT✓Other financing | Oct 2022 | $2.5M | — | European Innovation Council | — |
| EARLY VC✓Equity / VC | Oct 2022 | $0 | — | EIC Fund | — |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $900K | 0% | 20 |
| 2025 | $900K | 0% | 21 |
| 2024 | $900K | 0% | 16 |
| 2023 | $900K | — | 13 |
Growth signals
Arctic Therapeutics website traffic
Latest recorded traffic for Arctic Therapeutics is 1.4K monthly website visits, down 12.5% over the last three months. Arctic Therapeutics's team declined 4.8% over the past year.
Comparisons
Arctic Therapeutics compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Arctic Therapeutics's talent
Source: Dealroom Talent Intelligence.
Investors
7 investors on Arctic Therapeutics's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Arctic Therapeutics has talent and traffic
team presence
In the news
Latest news about Arctic Therapeutics
Recent press, funding announcements, and product moves mentioning Arctic Therapeutics — open to read from the original sources.
Market sentiment
What the market is saying about Arctic Therapeutics
An AI-synthesized read of the highest-engagement posts about Arctic Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Arctic Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.